STEQ America is dedicated to helping biotechnology and pharmaceutical companies find the right solutions to be leaders in their industry. A division of the STEQ group, which has been in operation for more than 20 years, STEQ America have garnered much success offering technology-led solutions to the pharmaceutical, biotech & life science industries. We are also much more than the solution providers for European and local manufacturers to be represented in the Americas. We are a team of great people, inspired by our ability to make a positive impact on the sectors we serve, by helping the companies within them discover healthcare solutions so that people may live happy and fulfilling lives. For the STEQ America organization, the customer relationship does not end at the delivery of the equipment. STEQ America Services cares to offer a unique and differentiated after-sales service, focused on customer needs related to the entire state of quality of the process and finished product. We provide you with customized training and services for our partner lines of equipment.
Our company was founded on the principles of a quality culture that fosters each individual employee’s talent, ideas, and keen motivation to be a powerful influence in the biotechnology and life sciences industries, through the development of our business and the customers we support.
Equipment and services for those involved in biotechnology and the life sciences with a focus on manufacturing. We offer advanced European solutions for steam sterilization, isolation technology, bioGO cGMP Cleanrooms, cGMP Washers, bioreactors and fermentation systems, magnetic agitators and more. Our partners include Matachana, IWT, ZETA, Germfree, Comecer, Düperthal, Memmert, Arctiko, and VICI DBS.
Welcome Pharma Focus Readers! Below you will find the Pharma Focus Winter 2019 edition, provided from IWT. Click the link to download the full version. Happy Pharma Days! Pharma Focus Edition 2
Today, in line with the evolution of bio-processing techniques to satisfy the concepts on Pharma 4.0, there is heavy emphasis on cell line and expression system improvements. With this background, the demands on bioreactors have become more exacting over recent years, requiring paradigm shifts in manufacturing efficiencies. Continuous optimization, design improvements and characterization of bioreactors are crucial factors placing high demands for innovation in bio-pharmaceutical manufacturing. Therefore, it is inevitable that a focus is placed on new approaches in plant engineering to keep pace with the technological developments of the bio-pharmaceutical industry.